Can provision of near vision glasses as an early intervention improve visual outcomes in infants at risk of perinatal brain insult? The Babies in Glasses (BiG) randomised feasibility trial.

Raimonda Bullaj, Leigh Dyet, Subhabrata Mitra, Catey Bunce, Caroline S Clarke, Kathryn Saunders, Naomi Dale, Anna Horwood, Cathy Williams, Helen St Clair Tracy, Neil Marlow, Richard Bowman

Journal: BMJ open 2026;16(2):e107894

PMID: 41698720

Abstract

OBJECTIVES

We conducted a feasibility study to evaluate the feasibility of recruiting patients to examine the effect of near vision glasses in young infants at risk of cerebral visual impairment.

DESIGN

A three-arm, parallel-group, open-label randomised feasibility trial.

SETTING

Tertiary neonatal intensive care in London, UK.

PARTICIPANTS

We included babies born before 29 weeks of gestation or at full term with hypoxic ischaemic encephalopathy. Babies who needed ongoing inpatient care, with established eye anomalies or with very high refractive errors at baseline (<-6.00 dioptres (D) or >±8.00D) were not included. Infants with retinopathy of prematurity were not excluded.

INTERVENTIONS

At 8 weeks corrected age, we allocated 18 infants to wear glasses (+3.00D over full cycloplegic refraction) immediately (intervention 1), 18 to wear the same glasses at 16 weeks (intervention 2) and 19 infants were allocated to standard treatment (no glasses).

OUTCOMES

Recruitment and retention of study participants (primary), compliance wearing glasses, preferential-looking visual acuity (with glasses) and visual function as determined using A Test Battery of Child Development for Examining Functional Vision at 3-month and 6-month age post-term.

RESULTS

Of 70 eligible families, 55 consented and 34 attended baseline assessments, and 28 completed the study. Non-attendance was due mainly to prolonged inpatient stay, infant health and scheduling conflicts. Glasses were worn for similar periods in each group (Intervention 1: median 2 hours/day (95% CI 1 hour to 4 hours); Intervention 2: median 2 hours/day (95% CI 1.5 hours to 3 hours)). Visual acuity improved from baseline to 6 months. Mean (SE) LogMAR (Minimum Angle of Resolution) improvements were standard care: 0.47 (0.45); intervention 1: 0.66 (0.44); intervention 2: 0.37 (0.36). Among the 29 very preterm infants, there were similar findings: standard care: 0.35 (0.35); Intervention 1: 0.67 (0.47); Intervention 2: 0.34 (0.40). As a functional measure, object permanence was present at the following rates by randomised arm: standard care: 29%; whereas intervention 1: 56%; and intervention 2: 44% (OR intervention 1 vs standard care: 3.13 (95% CI 0.38 to 25.57), ie, not statistically significant).

CONCLUSIONS

We demonstrate feasibility for a definitive RCT (randomized controlled trial) with good recruitment and retention and observed potential benefits for vision and development following the dispensing of glasses at 8 weeks post-term age compared with untreated controls. We identified methodological modifications to further improve recruitment processes for a future larger study.

TRIAL REGISTRATION NUMBERS

ISRCTN14646770; NCT05048550.

© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group.

Address: Ophthalmology, Great Ormond Street Hospital NHS Trust, London, UK.; Institute for Women's Health, University College London Hospitals NHS Foundation Trust, London, UK.; Institute for Women's Health, University College London Hospitals NHS Foundation Trust, London, UK.; University College London, London, UK.; London School of Hygiene & Tropical Medicine Faculty of Infectious and Tropical Diseases, London, UK.; Research Department of Primary Care and Population Health, University College London, UCL Medical School, UK.; Biomedical Sciences Research Institute, Ulster University, Coleraine, UK.; Great Ormond Street Hospital for Children, London, UK.; School of Psychology, University of Reading, Reading, UK.; Bristol Medical School, University of Bristol, Bristol, UK.; University of Bristol, Bristol, UK.; School of Medicine, University of St Andrews, St Andrews, UK.; International Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK [email protected].; Institute of Child Health, UCL, London, UK.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.